Concepedia

Tomas Lorant

TL

Statistics

Publications

21

Citations

1.2K

H-Index

17

Active since

2007

Affiliations

Uppsala University(Current)

Uppsala University Hospital

Hansa Biopharma (Sweden)

Karolinska Institutet

Cedars-Sinai Medical Center

Tomas Lorant is an author at Uppsala University specializing in medicine, kidney transplantation, and immunology.

Publications per year

2007–2024

21

Publications

21

IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation

Stanley C. Jordan, Tomas Lorant, Jua Choi et al. · New England Journal of Medicine · 2017 · 364 citations · Full text

Medicine, Immunology, Nephrology +15

Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)

Stanley C. Jordan, Christophe Legendre, Niraj M. Desai et al. · Transplantation · 2020 · 114 citations · Full text

Life Sciences, Immunology, Pharmacokinetics +17

Safety, immunogenicity, pharmacokinetics, and efficacy of degradation of anti-HLA antibodies by IdeS (imlifidase) in chronic kidney disease patients

Tomas Lorant, Mats Bengtsson, Torsten Eich et al. · American Journal of Transplantation · 2018 · 105 citations · Full text

Life Sciences, Immunology, Pharmacology +14

T Lymphocyte Trafficking: A Novel Target for Neuroprotection in Traumatic Brain Injury

Fredrik Clausen, Tomas Lorant, Anders Lewén et al. · Journal of Neurotrauma · 2007 · 93 citations

Life Sciences, Immunology, Neuroscience +17

Outcomes at 3 years posttransplant in imlifidase-desensitized kidney transplant patients

Christian Kjellman, Angela Q. Maldonado, Kristoffer Sjöholm et al. · American Journal of Transplantation · 2021 · 92 citations · Full text

Medicine, Immunology, Surgery +17

1–5 of 21